LAWRENCE DAVID 4

Accession 0001209191-18-036828

CIK 0001008848other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 7:44 AM ET

Size

22.3 KB

Accession

0001209191-18-036828

Insider Transaction Report

Form 4

Period: 2018-06-07

ACORDA THERAPEUTICS INCACOR

LAWRENCE DAVID

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2018-06-08$20.59/sh+5,120$105,421→ 13,244 total
Sale
Common Stock
2018-06-08$33.10/sh−20$662→ 8,124 total
Exercise/Conversion
Common Stock
2018-06-07$20.59/sh+19,880$409,329→ 28,004 total
Sale
Common Stock
2018-06-07$28.02/sh−19,880$556,976→ 8,124 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-06-08−5,120→ 0 total
Exercise: $20.59Exp: 2019-03-02→ Common Stock (5,120 underlying)
Sale
Common Stock
2018-06-08$29.61/sh−400$11,845→ 8,844 total
Sale
Common Stock
2018-06-08$30.58/sh−500$15,290→ 8,344 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-06-07−19,880→ 5,120 total
Exercise: $20.59Exp: 2019-03-02→ Common Stock (19,880 underlying)
Sale
Common Stock
2018-06-08$28.41/sh−4,000$113,630→ 9,244 total
Sale
Common Stock
2018-06-08$31.90/sh−200$6,380→ 8,144 total

Footnotes (7)

[F1]Exercises and sales pursuant to a 10b5-1 plan.
[F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.00 to $28.20 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.30 to $29.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $29.30 to $30.20 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.35 to $31.00 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.70 to $32.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F7]The shares subject to these options vested in installments and were fully vested on 01/01/2013.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ACORDA THERAPEUTICS INC

CIK 0001008848

→

Entity typeother

Related Parties

filerCIK 0001272353

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 7:44 AM ET
Size: 22.3 KB

View on SEC.gov